SCHEMBL20370680

SCHEMBL20370680

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)Sc4nc6ccccc6nc4S5)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ NTSR1 P30989 1/20 0.37
▸ PIK3CA P42336 2/20 0.36
▸ PI4KA P42356 1/20 0.36
▸ PI4KB Q9UBF8 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ BACE1 P56817 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA2B P29275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370741 0.94 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20370670 0.94 PIK3CA (0.40) MEN1KMT2AALDH1A1L3MBTL1PIK3CA
SCHEMBL20370728 0.90 PIK3CA (0.38) MEN1KMT2AL3MBTL1PIK3CAPI4KA
SCHEMBL20370672 0.86 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20370694 0.82 DHODH (0.35) PIK3CAPI4KAPI4KBBACE1
SCHEMBL20370720 0.82 PIK3CA (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20370729 0.81 SRC (0.44) ALDH1A1MAPTHPGDADORA2AADORA1
SCHEMBL20370744 0.81 MAPT (0.35) MEN1KMT2AALDH1A1MAPTPIK3CA
SCHEMBL20370689 0.80 MAPT (0.33) MAPTPIK3CAPI4KAPI4KBBACE1
SCHEMBL20370705 0.80 L3MBTL1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-01 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CRY2, CYP1A1 MEN1 382/4885KMT2A 992/4885ALDH1A1 24/4885
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CYP1A1 MEN1 382/4885KMT2A 992/4885ALDH1A1 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback